GIGABYTE
14.4.2020 11:02:06 CEST | Business Wire | Press release
The leading personal computer brand, GIGABYTE, recently received the 2020 Red Dot Design Award for two creator laptops from the AERO line – AERO 15 OLED & AERO 17 – as well as two professional gaming laptops – AORUS 15G and AORUS 17X. The recognition further establishes GIGABYTE’s role as a market leader in the laptop industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200414005017/en/
There were over 6,500 entries from 60 countries contending in this year’s Red Dot Design Awards. GIGABYTE is committed to producing the AERO Creator Laptop and AORUS Gaming Laptop lines in Taiwan. With their ultra-slim bezel, Xrite Pantone color calibration, Microsoft Azure AI, and other industry leading technologies, GIGABYTE’s laptops have already been recognised with the European Hardware Awards for Best Notebook as well as receiving Taiwan Excellence Awards. The notebooks are now honored with the 2020 Red Dot Design Award.
AORUS: Redefining Gaming Laptops
AORUS laptops are fast and powerful, with screens that offer a high refresh rate coupled with exceptional mechanical keyboards. In 2020, AORUS takes it further by collaborating with G2 Esports, a professional global esports team, to develop a purpose-built gaming laptop that caters to professional gamer’s needs. The comprehensive and integrative design concept was crucial for GIGABYTE in winning the award.
The product design is infused with a sense of extreme performance, with the flagship AORUS 17X being inspired by super cars and a fighter jet. The chassis is created using CNC (Computer Numerical Control) technology, carving the all-aluminum chassis into a robust frame with defined angles. RGB LED lights are scattered from end to end showcasing the flagship laptop’s overwhelming speed and power.
The second winning laptop, the brand new AORUS 15G, is a professional gaming laptop for on-the-road gamers: though also equipped with a mechanical keyboard, the AORUS 15G is lighter and has a longer lasting battery. The design of AORUS 15G was also inspired by sports cars with the side of the chassis embellished with faux race car features to create a feel of extreme sports while adding a touch of minimalist modernism.
AERO: An Equilibrium of Performance and Mobility
The aesthetic of the creator laptops in the AERO line are inspired by science fiction films. The full aluminum chassis is finished with NIL (Nano-Imprint Lithography), presenting superior quality that is simple but by no means underwhelming. Steven Chen, VP of GIGABYTE’s Mobile Business Center, stated that the beauty of AERO laptops lies in “more possibilities” and therefore they must have lighter bodies, long-lasting batteries, and great performance without any compromise due to overheating.
The AERO line is well-balanced in many aspects, visual artist Rus Khasonov was inspired by AERO to create videos with the AERO 15 OLED, “With AERO, I can render with After Effects and edit with Photoshop at the same time. I’m deeply impressed that such a light body can offer such performance.”
The full line of creator laptops from AERO, including the 15” AERO 15 OLED and 17” AERO 17 HDR with 4K monitors as well as the AERO 15 and AERO 17 with FHD monitors, are available starting on 16th April. The graphics card powerhouse, NVIDIA, is upping the prize for creators and has promised free access to Adobe Creative Cloud for three months to anyone buying the RTX Studio equipped models. For details, please refer to the official website: https://www.gigabyte.com/Laptop
- ENDS -
About GIGABYTE
GIGABYTE is an engineer, visionary, and leader in the world of tech that uses its hardware expertise, patented innovations, and industry leadership to create, inspire and advance. Renowned for over 30 years of award-winning excellence, GIGABYTE is a cornerstone in the HPC community, providing businesses with server and data center expertise to accelerate their success. At the forefront of evolving technology, GIGABYTE is devoted to inventing smart solutions that enable digitalization from edge to cloud, and allow customers to capture, analyze, and transform digital information into economic data that can benefit humanity and "Upgrade Your Life". Please visit https://www.gigabyte.com/ for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200414005017/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom